SCHEMBL7654710

SCHEMBL7654710

CCN(CC)c1ccc(NC(=O)C(c2ccccc2)C2CCCCN2)cc1

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 8/20 0.57
SLC6A2 P23975 6/20 0.57
SLC6A4 P31645 4/20 0.57
DHFR P00374 1/20 0.57
LMNA P02545 2/20 0.56
ALDH1A1 P00352 1/20 0.56
TSHR P16473 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
HTR1E P28566 2/20 0.51
S1PR3 Q99500 2/20 0.51
MEN1 O00255 1/20 0.50
MAPT P10636 1/20 0.50
KMT2A Q03164 1/20 0.50
RAB9A P51151 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7649404 0.83 HTR1E (0.70) SLC6A3SLC6A2LMNATSHRTDP1
SCHEMBL15966790 0.75 SLC6A3 (0.64) SLC6A3SLC6A2SLC6A4DHFRLMNA
SCHEMBL12904188 0.74 SLC6A3 (0.70) SLC6A3SLC6A2SLC6A4DHFRLMNA
SCHEMBL14906223 0.74 SLC6A3 (0.70) SLC6A3SLC6A2SLC6A4DHFRLMNA
SCHEMBL17084398 0.74 SLC6A3 (1.00) SLC6A3SLC6A2SLC6A4DHFRLMNA
SCHEMBL6099068 0.73 SLC6A3 (0.78) SLC6A3SLC6A2SLC6A4DHFRLMNA
SCHEMBL14453321 0.73 SLC6A3 (0.78) SLC6A3SLC6A2SLC6A4DHFRLMNA
SCHEMBL12550069 0.73 SLC6A3 (0.78) SLC6A3SLC6A2SLC6A4DHFRLMNA
SCHEMBL20850913 0.73 SLC6A3 (0.78) SLC6A3SLC6A2SLC6A4DHFRLMNA
SCHEMBL1462581 0.73 SLC6A3 (0.78) SLC6A3SLC6A2SLC6A4DHFRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407120-B1 ADMINISTERING PYRIDINYLACETAMIDE OR PHENYLACETAMIDE DERIVATIVE TO TREAT CARDIOVASCULAR, EATING, SEXUAL, BRAIN, NERVOUS SYSTEM, GASTROINTESTINAL, UROGENITAL, PSYCHOLOGICAL, AND RESPIRATORY SYSTEM DISORDERS PFIZER INC. 2002-06-18 US disclosed
EP-1033366-A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists Pfizer Products Inc. (US) 2000-09-06 EP disclosed